Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis

Clinical and Vaccine Immunology

Volumn 19, Issue 9, 2012, Pages 1339-1347

  Pérez De Val, Bernat ^a   Villarreal Ramos, Bernardo ^b   Nofrarías, Miquel ^a   López Soria, Sergio ^a   Romera, Nadine ^c   Singh, Mahavir ^d   Abad, F Xavier ^a   Xing, Zhou ^e   Vordermeier, H Martin ^b   Domingo, Mariano ^a,f  

^a CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

^c Radiology Service   (Spain)

^d LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH   (Germany)

^e MCMASTER UNIVERSITY   (Canada)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE; BIOLOGICAL MARKER; GAMMA INTERFERON; PROTEIN AG85A; UNCLASSIFIED DRUG;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; GOAT; HUMORAL IMMUNITY; INFECTION PREVENTION; INTERFERON PRODUCTION; LUNG TUBERCULOSIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYCOBACTERIUM; MYCOBACTERIUM CAPRAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS; VIRUS RECOMBINANT;

ACYLTRANSFERASES; ADENOVIRIDAE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FEMALE; GENETIC VECTORS; GOATS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LUNG; LYMPH NODES; MYCOBACTERIUM BOVIS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINATION; VACCINES, SYNTHETIC;

EID: 84865957269     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00275-12     Document Type: Article

References (39)

1. Andersen P, Doherty TM, Pai M, Weldingh K. 2007. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol. Med. 13:175-182. (Pubitemid 46687128)
2. Aranaz A, Cousins D, Mateos A, Dominguez L. 2003. Elevation of Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to species rank as Mycobacterium caprae comb. nov., sp. nov. Int. J. Syst. Evol. Microbiol. 53:1785-1789.
3. Brewer TF. 2000. Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature. Clin. Infect. Dis. 31:S64-S67. (Pubitemid 32269590)
4. Buddle BM, de Lisle GW, Pfeffer A, Aldwell FE. 1995. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13:1123-1130.
5. Buddle BM, Wedlock DN, Denis M, Skinner MA. 2005. Identification of immune response correlates for protection against bovine tuberculosis. Vet. Immunol. Immunopathol. 108:45-51. (Pubitemid 41317065)
6. Buddle BM, et al. 2003. Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect. Immun. 71:6411-6419. (Pubitemid 37337700)
7. Cockle PJ, Gordon SV, Hewinson RG, Vordermeier HA. 2006. Field evaluation of a novel differential diagnostic reagent for detection of Mycobacterium bovis in cattle. Clin. Vaccine Immunol. 13:1119-1124. (Pubitemid 44622539)
8. Colditz GA, et al. 1995. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: metaanalyses of the published literature. Pediatrics 96:29-35.
9. Corner LAL, Trajstman AC. 1988. An evaluation of 1-hexadecylpyridinium chloride as a decontaminant in the primary isolation of Mycobacterium bovis from bovine lesions. Vet. Microbiol. 18:127-134. (Pubitemid 18268471)
10. Corner LAL, Costello E, Lesellier S, O'Meara D, Gormley E. 2008. Vaccination of European badgers (Meles meles) with BCG by the subcutaneous and mucosal routes induces protective immunity against endobronchial challenge with Mycobacterium bovis. Tuberculosis (Edinb.) 88: 601-609.
11. Cvetnic Z, et al. 2007. Mycobacterium caprae in cattle and humans in Croatia. Int. J. Tuberc. Lung Dis. 11:658.
12. de la Rua-Domenech R, et al. 2006. Ante mortem diagnosis of tuberculosis in cattle: a review of the tuberculin tests, γ-interferon assay and other ancillary diagnostic techniques. Res. Vet. Sci. 81:190-210. (Pubitemid 43905909)
13. Domingo M, et al. 2009. Effectiveness and safety of a treatment regimen based on isoniazid plus vaccination with Mycobacterium tuberculosis cells? Fragments: field-study with naturally Mycobacterium caprae-infected goats. Scand. J. Immunol. 69:500-507.
14. Duarte EL, Domingos M, Amado A, Botelho A. 2008. Spoligotype diversity of Mycobacterium bovis and Mycobacterium caprae animal isolates. Vet. Microbiol. 130:415-421.
15. Flynn J, et al. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254. (Pubitemid 23344886)
16. Flynn JL. 2004. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb.) 84:93-101. (Pubitemid 38087953)
17. Hope JC, et al. 2005. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clin. Exp. Immunol. 139:48-56. (Pubitemid 40066128)
18. Kubica T, Rusch-Gerdes S, Niemann S. 2003. Mycobacterium bovis subsp. caprae caused one-third of human M. bovis-associated tuberculosis cases reported in Germany between 1999 and 2001. J. Clin. Microbiol. 41:3070-3077. (Pubitemid 36842304)
19. Lesellier S, et al. 2009. Immunological responses and protective immunity in BCG vaccinated badgers following endobronchial infection with Mycobacterium bovis. Vaccine 27:402-409.
20. McShane H, Hill A. 2005. Prime-boost immunisation strategies for tuberculosis. Microbes Infect. 7:962-967. (Pubitemid 40826666)
21. Pai M, Riley LW, Colford John JM. 2004. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 4:761-776.
22. Pérez de Val B, et al. 2011. Experimental model of tuberculosis in the domestic goat after endobronchial infection with Mycobacterium caprae. Clin. Vaccine Immunol. 18:1872-1881.
23. Prodinger WM, et al. 2005. Characterization of Mycobacterium caprae isolates from Europe by mycobacterial interspersed repetitive unit genotyping. J. Clin. Microbiol. 43:4984-4992. (Pubitemid 41483994)
24. Rodrigues LC, Diwan VK, Wheeler JG. 1993. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int. J. Epidemiol. 22:1154-1158. (Pubitemid 24025695)
25. Rodríguez E, et al. 2009. Human tuberculosis due to Mycobacterium bovis and M. caprae in Spain, 2004-2007. Int. J. Tuberc. Lung Dis. 13: 1536-1541.
26. Rodriguez S, et al. 2011. Mycobacterium caprae infection in livestock and wildlife, Spain. Emerg. Infect. Dis. 17:532-535.
27. Sander CR, et al. 2009. Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals. Am. J. Respir. Crit. Care Med. 179:724-733.
28. Santosuosso M, McCormick S, Zhang X, Zganiacz A, Xing Z. 2006. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect. Immun. 74:4634-4643. (Pubitemid 44157251)
29. Sharpe SA, et al. 2009. Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis. Tuberculosis (Edinb.) 89: 405-416.
30. Sharpe SA, et al. 2010. Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing. Clin. Vaccine Immunol. 17:1170-1182.
31. Sidders B, et al. 2008. Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential diagnostic antigen for the Mycobacterium tuberculosis complex. Infect. Immun. 76:3932-3939.
32. Vordermeier HM, et al. 2002. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 70:3026-3032. (Pubitemid 34564163)
33. Vordermeier HM, et al. 2001. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin. Diagn. Lab. Immunol. 8:571-578. (Pubitemid 32428883)
34. Vordermeier HM, Huygen K, Singh M, Hewinson RG, Xing Z. 2006. Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing mycobacterial antigen 85A and Mycobacterium bovis BCG. Infect. Immun. 74:1416-1418. (Pubitemid 43185586)
35. Vordermeier HM, et al. 2009. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect. Immun. 77:3364-3373.
36. Wang J, et al. 2004. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J. Immunol. 173:6357-6365. (Pubitemid 39487795)
37. Wedlock DN, Denis M, Vordermeier HM, Hewinson RG, Buddle BM. 2007. Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induces different levels of IFN gamma postvaccination, but induces similar levels of protection against bovine tuberculosis. Vet. Immunol. Immunopathol. 118:50-58. (Pubitemid 46962705)
38. Xing Z, Charters TJ. 2007. Heterologous boost vaccines for bacillus Calmette-Guerin prime immunization against tuberculosis. Expert Rev. Vaccines 6:539-546. (Pubitemid 47287482)
39. Young D. 2009. Animal models of tuberculosis. Eur. J. Immunol. 39: 2011-2014.